U.S. Physical Therapy assumed with an Overweight at JPMorgan

JPMorgan analyst Benjamin Rossi assumed coverage of U.S. Physical Therapy (USPH) with an Overweight rating and $110 price target The firm views current outpatient environment to be most favorable for companies with lower reimbursement exposure to federal funding. The analyst believes U.S. Physical Therapy is well positioned to benefit from long-term demographic trends.